
Kanceftri TZ 250mg/31.25mg Injection
Marketer
Fortune Life Sciences Private Limited
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Kanceftri TZ 250mg/31.25mg Injection
Cefuroxime Axetil and Sulbactam injection (250mg/31.25mg) is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under a doctor's guidance. Strictly adhere to the prescribed dosage schedule; complete the entire course even with symptom improvement. Premature cessation can compromise treatment efficacy. Minor side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Report any worsening side effects immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Inform your doctor about all current medications, including those for pre-existing conditions, before starting this treatment. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor the medication's effects.
Primary Ingredients of Kanceftri TZ 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Kanceftri TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Kanceftri TZ 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Kanceftri TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Kanceftri TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kanceftri TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Kanceftri TZ 250mg/31.25mg) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth. Tazobactam counters bacterial resistance, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Kanceftri TZ 250mg/31.25mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Kanceftri TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Kanceftri TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
The injection Kanceftri TZ (250mg/31.25mg) can reduce awareness, impair vision, and induce drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kanceftri TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Kanceftri TZ 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Seek medical advice. Dosage alterations for Kanceftri TZ 250mg/31.25mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Kanceftri TZ 250mg/31.25mg Injection :
Omit a Kanceftri TZ 250mg/31.25mg Injection dose? Seek medical advice immediately.
Facts to Know About Kanceftri TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
